3Tasdelen Fisgin N,Aliyazicioglu Y,Coban Y,et al.The value of neopterin and procalcitonin in patients with sepsis[J].South Medcine,2010,103(3):216-219.
4Hur M,Moon HW,Yun YM,et al.Comparison of Diagnostic Utility between Procalcitonin and C-Reactive Protein for the Patients with Blood Culture-Positive Sepsis[J].Korean J Lab Med,2009,29(6):529-535.
5Bafadhel M,MBCh B,Tristan W,et al.Procalcitonin andC-Reactive Protein in Hospitalized Adult Patients WithCommunity-Acquired Pneumonia or Exacerbation of Asthma orCOPD[J].Chest,2011,139(6):1410-1418.
7Walid S,Anna F,Hana E,et al.Trends in the burden of infectious disease hospitalizations among the elderly in the last decade[J].European Journal of Internal Medicine,2013,24(6):536-540
8Christopher AT,Robert CH,Laura SC,et al.Unexplained death due to possible infectious diseases in infants-united states,2006[J].The Journal of Pediatrics,2013,162(1):195-201
9Iris RB,Gary ES,Nancy NB,et al.Advances in integrative nanomedicine for improving infectious disease treatment in public health[J].European Journal of Integrative Medicine,2013,5(2):126-140
10Ceddia MG,Bardsley NO,Goodwin R,et al.A complex system perspective on the emergence and spread of infectious diseases:Integrating economic and ecological aspects[J].Ecological Economics,2013,90(1):124-131
